Get started
Author

N. Blondheim-Shraga

Observed names: Netta Blondheim, Netta R. Blondheim, Netta R. Blondheim Shraga, Netta R. Blondheim-Shraga, Netta R. Blondheim‐Shraga, Netta R. Shraga, Netta Rose Blondheim Shraga, Netta Shraga
ORCID: 0000-0002-6072-5623
Observed ORCID: 0000-0002-6072-5623
OpenAlex ID: A5041204256
Human Mesenchymal Stem Cells Express Neural Genes, Suggesting a Neural Predisposition
2006 · Netta R. Blondheim, Yossef S. Levy, et al. · Stem Cells and Development · 171
LifeMap Discovery™: The Embryonic Development, Stem Cells, and Regenerative Medicine Research Portal
2013 · Ron Edgar, Yaron Mazor, et al. · PLoS ONE · 98
PDF
Erythropoietin delays disease onset in an amyotrophic lateral sclerosis model
2006 · Jonathan F. Grunfeld, Yael Barhum, et al. · Experimental Neurology · 49
Experimental Encephalomyelitis Induces Changes in DJ-1: Implications for Oxidative Stress in Multiple Sclerosis
2006 · Nirit Lev, Debby Ickowicz, et al. · Antioxidants and Redox Signaling · 32
Identification of Tumor Antigens in the HLA Peptidome of Patient-derived Xenograft Tumors in Mouse
2020 · Nataly Mancette Rijensky, Netta R. Blondheim Shraga, et al. · Molecular & Cellular Proteomics · 18
Resolving the conflicts around Par2 opposing roles in regeneration by comparing immune-mediated and toxic-induced injuries
2022 · Gal Reches, Netta R. Blondheim Shraga, et al. · Inflammation and Regeneration · 10
PDF
Debamestrocel multimodal effects on biomarker pathways in amyotrophic lateral sclerosis are linked to clinical outcomes
2024 · Stacy R. Lindborg, Namita A. Goyal, et al. · Muscle & Nerve · 6
PDF
Beneficial effects of small extracellular vesicles derived from MSC-NTF (NurOwn®) cells on lung inflammation and fibrosis
2026 · Haggai Kaspi, Chen Dekel, et al. · Stem Cell Research & Therapy
Debamestrocel Effect on Clinical and Biomarker Endpoints by Unc13a Genotypes in Phase 3 Als Trial
2025 · B. Dagher, J. Berry, et al. · Cytotherapy
Small Extracellular Vesicles From MSC-NTF Cells Induce Significant Improvement in Inflammatory Lung Disease Models
2023 · H. Kaspi, C. Dekel, et al.
Mesenchymal Stem/Stromal Cells: CONSIDERATION OF COMPARTMENT EFFECT ON BIOMARKER ANALYSIS: LESSONS LEARNED FROM BRAINSTORM’S PHASE III CLINICAL TRIAL EVALUATING MSC-NTF CELL THERAPY IN ALS
2023 · N. Blondheim-Shraga, H. Kaspi, et al. · Cytotherapy
Opposite PAR2 roles in liver regeneration from autoimmune or direct damage. Solving the conflict
2022 · Gal Reches, Netta Rose Blondheim Shraga, et al. · Journal of Hepatology
Abstract 2297: Anti-labyrinthin monoclonal antibody reduces human adenocarcinoma circulating tumor cells in the blood of patient-derived xenograft models and inhibits the growth of adenocarcinoma cell cultures
2019 · Natalia Saleev, Netta R. Blondheim-Shraga, et al. · Cancer Research
Abstract 2297: Anti-labyrinthin monoclonal antibody reduces human adenocarcinoma circulating tumor cells in the blood of patient-derived xenograft models and inhibits the growth of adenocarcinoma cell cultures
2019 · Natalia Saleev, Netta R. Blondheim-Shraga, et al. · Clinical Research (Excluding Clinical Trials)
Abstract 2754: NT219, a novel dual inhibitor of STAT3 and IRS1/2, converts immuno-oncology resistant tumors to responders
2018 · Lana Kuperschmidt, Hadas Reuveni, et al. · Cancer Research
Abstract 1030: Circulating tumor cells from patients' blood induce tumors in a personalized xenograft mouse model: A functional approach to assess the patients' premetastatic disease state
2018 · Netta R. Shraga, Amihai Lieberman, et al. · Cancer Research
Works count: 16
Citation count: 384
H-index: 6
I10-index: 6
Year
Topic
Type